These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 20655882)
21. The 18-kDa mitochondrial translocator protein in gliomas: from the bench to bedside. Janczar K; Su Z; Raccagni I; Anfosso A; Kelly C; Durrenberger PF; Gerhard A; Roncaroli F Biochem Soc Trans; 2015 Aug; 43(4):579-85. PubMed ID: 26551696 [TBL] [Abstract][Full Text] [Related]
22. The role of 18 kDa mitochondrial translocator protein (TSPO) in programmed cell death, and effects of steroids on TSPO expression. Veenman L; Gavish M Curr Mol Med; 2012 May; 12(4):398-412. PubMed ID: 22348610 [TBL] [Abstract][Full Text] [Related]
23. Effects of 18-kDa translocator protein knockdown on gene expression of glutamate receptors, transporters, and metabolism, and on cell viability affected by glutamate. Veenman L; Bode J; Gaitner M; Caballero B; Peʼer Y; Zeno S; Kietz S; Kugler W; Lakomek M; Gavish M Pharmacogenet Genomics; 2012 Aug; 22(8):606-19. PubMed ID: 22732722 [TBL] [Abstract][Full Text] [Related]
24. Translocator protein (TSPO) ligand-Ara-C (cytarabine) conjugates as a strategy to deliver antineoplastic drugs and to enhance drug clinical potential. Denora N; Laquintana V; Trapani A; Lopedota A; Latrofa A; Gallo JM; Trapani G Mol Pharm; 2010 Dec; 7(6):2255-69. PubMed ID: 20958082 [TBL] [Abstract][Full Text] [Related]
25. Cancer-related overexpression of the peripheral-type benzodiazepine receptor and cytostatic anticancer effects of Ginkgo biloba extract (EGb 761). Pretner E; Amri H; Li W; Brown R; Lin CS; Makariou E; Defeudis FV; Drieu K; Papadopoulos V Anticancer Res; 2006; 26(1A):9-22. PubMed ID: 16475673 [TBL] [Abstract][Full Text] [Related]
26. Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: applications in diagnostic imaging and therapy. Kashiwagi H; McDunn JE; Simon PO; Goedegebuure PS; Xu J; Jones L; Chang K; Johnston F; Trinkaus K; Hotchkiss RS; Mach RH; Hawkins WG Mol Cancer; 2007 Jul; 6():48. PubMed ID: 17631687 [TBL] [Abstract][Full Text] [Related]
27. CoCl(2) induces apoptosis via the 18 kDa translocator protein in U118MG human glioblastoma cells. Zeno S; Zaaroor M; Leschiner S; Veenman L; Gavish M Biochemistry; 2009 Jun; 48(21):4652-61. PubMed ID: 19358520 [TBL] [Abstract][Full Text] [Related]
28. Tetramethylpyrazine-mediated suppression of C6 gliomas involves inhibition of chemokine receptor CXCR4 expression. Yu K; Chen Z; Pan X; Yang Y; Tian S; Zhang J; Ge J; Ambati B; Zhuang J Oncol Rep; 2012 Sep; 28(3):955-60. PubMed ID: 22710373 [TBL] [Abstract][Full Text] [Related]
29. The translocator protein radioligand 18F-DPA-714 monitors antitumor effect of erufosine in a rat 9L intracranial glioma model. Awde AR; Boisgard R; Thézé B; Dubois A; Zheng J; Dollé F; Jacobs AH; Tavitian B; Winkeler A J Nucl Med; 2013 Dec; 54(12):2125-31. PubMed ID: 24212976 [TBL] [Abstract][Full Text] [Related]
30. Ligands of the mitochondrial 18 kDa translocator protein attenuate apoptosis of human glioblastoma cells exposed to erucylphosphohomocholine. Kugler W; Veenman L; Shandalov Y; Leschiner S; Spanier I; Lakomek M; Gavish M Cell Oncol; 2008; 30(5):435-50. PubMed ID: 18791274 [TBL] [Abstract][Full Text] [Related]
31. Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human esophageal cancer cells. Sutter AP; Maaser K; Höpfner M; Barthel B; Grabowski P; Faiss S; Carayon P; Zeitz M; Scherübl H Int J Cancer; 2002 Dec; 102(4):318-27. PubMed ID: 12402299 [TBL] [Abstract][Full Text] [Related]
32. Structural requirements to obtain highly potent and selective 18 kDa Translocator Protein (TSPO) Ligands. Taliani S; Pugliesi I; Da Settimo F Curr Top Med Chem; 2011; 11(7):860-86. PubMed ID: 21291396 [TBL] [Abstract][Full Text] [Related]
33. Peripheral benzodiazepine receptor ligand-PLGA polymer conjugates potentially useful as delivery systems of apoptotic agents. Laquintana V; Denora N; Musacchio T; Lasorsa M; Latrofa A; Trapani G J Control Release; 2009 Aug; 137(3):185-95. PubMed ID: 19374931 [TBL] [Abstract][Full Text] [Related]
34. The peripheral benzodiazepine receptor in photodynamic therapy with the phthalocyanine photosensitizer Pc 4. Morris RL; Varnes ME; Kenney ME; Li YS; Azizuddin K; McEnery MW; Oleinick NL Photochem Photobiol; 2002 Jun; 75(6):652-61. PubMed ID: 12081328 [TBL] [Abstract][Full Text] [Related]
35. Quantitative, preclinical PET of translocator protein expression in glioma using 18F-N-fluoroacetyl-N-(2,5-dimethoxybenzyl)-2-phenoxyaniline. Buck JR; McKinley ET; Hight MR; Fu A; Tang D; Smith RA; Tantawy MN; Peterson TE; Colvin D; Ansari MS; Baldwin RM; Zhao P; Guleryuz S; Manning HC J Nucl Med; 2011 Jan; 52(1):107-14. PubMed ID: 21149488 [TBL] [Abstract][Full Text] [Related]
37. Peripheral benzodiazepine receptor agonists exhibit potent antiapoptotic activities. Bono F; Lamarche I; Prabonnaud V; Le Fur G; Herbert JM Biochem Biophys Res Commun; 1999 Nov; 265(2):457-61. PubMed ID: 10558889 [TBL] [Abstract][Full Text] [Related]
38. Peripheral benzodiazepine receptor ligands: mitochondrial transmembrane potential depolarization and apoptosis induction in rat C6 glioma cells. Chelli B; Lena A; Vanacore R; Da Pozzo E; Costa B; Rossi L; Salvetti A; Scatena F; Ceruti S; Abbracchio MP; Gremigni V; Martini C Biochem Pharmacol; 2004 Jul; 68(1):125-34. PubMed ID: 15183124 [TBL] [Abstract][Full Text] [Related]
39. TSPO ligand residence time influences human glioblastoma multiforme cell death/life balance. Costa B; Da Pozzo E; Giacomelli C; Taliani S; Bendinelli S; Barresi E; Da Settimo F; Martini C Apoptosis; 2015 Mar; 20(3):383-98. PubMed ID: 25413799 [TBL] [Abstract][Full Text] [Related]
40. An update into the medicinal chemistry of translocator protein (TSPO) ligands. Barresi E; Robello M; Costa B; Da Pozzo E; Baglini E; Salerno S; Da Settimo F; Martini C; Taliani S Eur J Med Chem; 2021 Jan; 209():112924. PubMed ID: 33081988 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]